Location: Boston, MA
CIK: 0001816307 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value: $247M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SER TR | 200,000 | $22.39M | 9.1% | — | — | Call | 78464A870 |
| — | IMMUNOGEN INC | 1,514,411 | $11.24M | 4.6% | $7.12 | — | COM | 45253H101 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 80,348 | $11.07M | 4.5% | $94.83 | — | COM | G11196105 |
| — | INTRA-CELLULAR THERAPIES INC | 195,000 | $10.21M | 4.1% | $41.61 | — | COM | 46116X101 |
| — | MERUS N V | 320,174 | $10.18M | 4.1% | $21.01 | — | COM | N5749R100 |
| VCYT | VERACYTE INC | 221,362 | $9.12M | 3.7% | $47.16 | -6.3% | COM | 92337F107 |
| — | MIRATI THERAPEUTICS INC | 60,757 | $8.912M | 3.6% | $164.76 | — | COM | 60468T105 |
| — | BELLUS HEALTH INC NEW | 1,100,000 | $8.855M | 3.6% | $6.84 | — | COM NEW | 07987C204 |
| COGT | COGENT BIOSCIENCES INC | 850,935 | $7.301M | 3.0% | $8.41 | +3.3% | COM | 19240Q201 |
| GLPG | GALAPAGOS NV | 128,901 | $7.106M | 2.9% | $55.13 | — | SPON ADR | 36315X101 |
| CERS | CERUS CORP | 1,042,722 | $7.101M | 2.9% | $6.20 | +8.6% | COM | 157085101 |
| — | HORIZON THERAPEUTICS PUB L | 61,700 | $6.649M | 2.7% | $85.95 | — | SHS | G46188101 |
| — | ITEOS THERAPEUTICS INC | 138,006 | $6.426M | 2.6% | $29.25 | — | COM | 46565G104 |
| — | APOLLO ENDOSURGERY INC | 739,604 | $6.235M | 2.5% | $8.43 | — | COM | 03767D108 |
| — | RESEARCH ALLIANCE CORP II | 556,890 | $5.415M | 2.2% | $10.17 | — | COM CL A | 760873109 |
| IMTX | IMMATICS N.V | 391,155 | $5.257M | 2.1% | $12.03 | +3.9% | SHS | N44445109 |
| — | LUCIRA HEALTH INC | 515,000 | $4.434M | 1.8% | $8.18 | — | COM | 54948U105 |
| — | SIERRA ONCOLOGY INC | 192,045 | $4.175M | 1.7% | $17.70 | — | COM NEW | 82640U404 |
| ACRS | ACLARIS THERAPEUTICS INC | 286,226 | $4.162M | 1.7% | $17.82 | -15.0% | COM | 00461U105 |
| — | AMRYT PHARMA PLC | 350,213 | $3.782M | 1.5% | $13.80 | — | SPONSORED ADS | 03217L106 |
| — | CTI BIOPHARMA CORP | 1,483,829 | $3.68M | 1.5% | $2.48 | — | COM | 12648L601 |
| — | LEAP THERAPEUTICS INC | 1,013,664 | $3.284M | 1.3% | $3.71 | — | COM | 52187K101 |
| KRYS | KRYSTAL BIOTECH INC | 46,670 | $3.265M | 1.3% | $58.21 | 0.0% | COM | 501147102 |
| — | MORPHIC HLDG INC | 67,440 | $3.195M | 1.3% | $46.26 | — | COM | 61775R105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 111,860 | $3.178M | 1.3% | $23.00 | +7.2% | COM | 22663K107 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 14,551 | $3.144M | 1.3% | $177.28 | +10.7% | COM | 91307C102 |
| XENE | XENON PHARMACEUTICALS INC | 100,000 | $3.124M | 1.3% | $27.45 | +8.9% | COM | 98420N105 |
| HALO | HALOZYME THERAPEUTICS INC | 71,009 | $2.855M | 1.2% | $36.54 | +2.2% | COM | 40637H109 |
| INSM | INSMED INC | 100,621 | $2.741M | 1.1% | $36.67 | -22.0% | COM PAR $.01 | 457669307 |
| — | SERES THERAPEUTICS INC | 320,602 | $2.671M | 1.1% | $10.07 | — | COM | 81750R102 |
| CYTK | CYTOKINETICS INC | 58,190 | $2.652M | 1.1% | $30.84 | +25.1% | COM NEW | 23282W605 |
| — | OTONOMY INC | 1,199,814 | $2.496M | 1.0% | $3.08 | — | COM | 68906L105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 123,806 | $2.448M | 1.0% | $16.15 | +15.3% | COM | 92790C104 |
| VRAYQ | VIEWRAY INC | 427,847 | $2.357M | 1.0% | $5.97 | +2.0% | COM | 92672L107 |
| AUPH | AURINIA PHARMACEUTICALS INC | 100,000 | $2.287M | 0.9% | $23.70 | 0.0% | COM | 05156V102 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 181,886 | $2.226M | 0.9% | $11.89 | +13.2% | COM NEW | 30233G209 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 100,000 | $2.189M | 0.9% | $18.48 | 0.0% | COM | 87164F105 |
| STXS | STEREOTAXIS INC | 344,236 | $2.134M | 0.9% | $7.60 | -21.4% | COM NEW | 85916J409 |
| — | JOUNCE THERAPEUTICS INC | 245,829 | $2.053M | 0.8% | $7.21 | — | COM | 481116101 |
| — | CYCLACEL PHARMACEUTICALS INC | 458,466 | $1.783M | 0.7% | $6.08 | — | COM | 23254L603 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 45,132 | $1.744M | 0.7% | $42.13 | +3.4% | COM NEW | 15117B202 |
| — | ASLAN PHARMACEUTICALS LTD | 1,498,192 | $1.678M | 0.7% | $1.12 | — | ADS | 04522R101 |
| — | SEAGEN INC | 10,848 | $1.677M | 0.7% | $171.32 | — | COM | 81181C104 |
| BBIO | BRIDGEBIO PHARMA INC | 100,000 | $1.668M | 0.7% | $42.31 | 0.0% | COM | 10806X102 |
| — | POSEIDA THERAPEUTICS INC | 234,932 | $1.6M | 0.6% | $6.81 | — | COM | 73730P108 |
| — | DECIPHERA PHARMACEUTICALS IN | 160,526 | $1.568M | 0.6% | $20.66 | — | COM | 24344T101 |
| — | BENITEC BIOPHARMA INC | 587,499 | $1.539M | 0.6% | $3.97 | — | COM | 08205P100 |
| BIIB | BIOGEN INC | 5,744 | $1.378M | 0.6% | $311.09 | -17.3% | COM | 09062X103 |
| — | ELOXX PHARMACEUTICALS INC | 1,930,092 | $1.363M | 0.6% | $1.54 | — | COM | 29014R103 |
| MLTX | HELIX ACQUISITION CORP | 131,823 | $1.304M | 0.5% | $11.28 | — | COM CL A | G4444C102 |
| — | MEDICUS SCIENCES ACQUISITION | 128,582 | $1.246M | 0.5% | $9.66 | — | CL A SHS | G5960S108 |
| — | POLYPID LTD | 215,620 | $1.238M | 0.5% | $8.46 | — | SHS | M8001Q118 |
| — | SOCIAL CAP SUVRETTA HLDS CRP | 123,862 | $1.23M | 0.5% | $10.09 | — | CLASS A ORD SHS | G8253T106 |
| — | SOCIAL CAP SUVRETTA HLD CRPI | 123,862 | $1.226M | 0.5% | $10.08 | — | CLASS A ORD SHS | G8253W109 |
| — | SOCIAL CAP SUVRETTA HLDS CRP | 123,862 | $1.225M | 0.5% | $10.09 | — | CLASS A ORD SHS | G8253U103 |
| — | SOCIAL CAP SUVRETTA HLDS CP | 123,862 | $1.216M | 0.5% | $10.06 | — | CLASS A ORD SHS | G8253Y105 |
| — | NEXTCURE INC | 193,012 | $1.158M | 0.5% | $7.25 | — | COM | 65343E108 |
| — | POINT BIOPHARMA GLOBAL INC | 204,462 | $1.145M | 0.5% | $6.34 | — | COM | 730541109 |
| VRTX | VERTEX PHARMACEUTICALS INC | 5,000 | $1.098M | 0.4% | $194.45 | 0.0% | COM | 92532F100 |
| — | INHIBRX INC | 24,666 | $1.077M | 0.4% | $43.66 | — | COM | 45720L107 |
| — | CURIS INC | 200,000 | $952K | 0.4% | $8.68 | — | Call | 231269200 |
| KURA | KURA ONCOLOGY INC | 66,812 | $935K | 0.4% | $31.98 | -49.3% | COM | 50127T109 |
| IPHA | INNATE PHARMA S A | 184,046 | $839K | 0.3% | $4.56 | — | SPONSORED ADS | 45781K204 |
| — | VISTAGEN THERAPEUTICS INC | 424,181 | $827K | 0.3% | $3.10 | — | COM NEW | 92840H202 |
| CGEN | COMPUGEN LTD | 162,602 | $699K | 0.3% | $10.15 | -46.7% | ORD | M25722105 |
| — | EVOGENE LTD | 293,057 | $481K | 0.2% | $4.20 | — | SHS | M4119S104 |
| MREO | MEREO BIOPHARMA GROUP PLC | 233,183 | $373K | 0.2% | $3.35 | — | ADS | 589492107 |
| CGEN | COMPUGEN LTD | 57,000 | $245K | 0.1% | $10.15 | -46.7% | Call | M25722105 |
| — | CALITHERA BIOSCIENCES INC | 219,791 | $146K | 0.1% | $2.15 | — | COM | 13089P101 |
| — | RENOVACOR INC | 104,828 | $60,000 | 0.0% | $0.40 | — | *W EXP 99/99/999 | 75989E114 |
| — | MEDICUS SCIENCES ACQUISITION | 49,990 | $36,000 | 0.0% | $1.00 | — | *W EXP 02/12/202 | G5960S124 |